title: The combination of naratriptan and prochlorperazine in migraine treatment.
authors.affiliation: Department of Neurology, Medical College of Ohio, 3120 Glendale Avenue, Toledo, OH 43614, USA.
authors.forename: Gretchen E
authors.initials: GE
authors.lastname: Tietjen
authors.forename: Kathy
authors.initials: K
authors.lastname: Athanas
authors.forename: Christine
authors.initials: C
authors.lastname: Utley
authors.forename: Nabeel A
authors.initials: NA
authors.lastname: Herial
authors.forename: Sadik A
authors.initials: SA
authors.lastname: Khuder
mesh_terms: D000328:Adult; D018492:Dopamine Antagonists / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D008875:Middle Aged; D008881:Migraine Disorders / Q000188:drug therapy*; D010880:Piperidines / Q000627:therapeutic use*; D011346:Prochlorperazine / Q000627:therapeutic use*; D011446:Prospective Studies; D017366:Serotonin Receptor Agonists / Q000627:therapeutic use*; D014363:Tryptamines
chemical_list: D018492:Dopamine Antagonists; D007211:Indoles; D010880:Piperidines; D017366:Serotonin Receptor Agonists; D014363:Tryptamines; C106783:naratriptan; D011346:Prochlorperazine